The Effect of Reiki on Hopelessness Level

April 24, 2025 updated by: Saglik Bilimleri Universitesi

The Effect of Reiki on Hopelessness Level in Oncology Patients Receiving Chemotherapy Treatment; Randomised Controlled Trial

This quasi-experimental study aims to examine the effect of Reiki on the level of hopelessness in oncology patients.

The study was conducted at İzmir Tepecik Training and Research Hospital with 32 patients in both experimental and control groups. Patients performed Reiki daily for a week following each chemotherapy session for 4 cycles. Data were collected using the "Individual Information Form" and the "Beck Hopelessness Scale" through face-to-face and telephone interviews. Ethical approval was obtained, and data were analyzed using SPSS.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Reiki is considered a complementary and alternative therapy method that can be effective in coping with such emotional challenges and enhancing psychological well-being. It is thought that Reiki practices, by regulating the flow of energy and providing deep relaxation, can reduce individuals' levels of hopelessness and improve overall quality of life. This study will investigate the effect of Reiki practices on the levels of hopelessness in oncology patients.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey, 34668
        • Health Science University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

inclusion criteria: Receiving treatment at the Outpatient Chemotherapy Unit of İzmir Tepecik Training and Research Hospital University of Health Sciences, Diagnosed with cancer, Aged 18 and over, Willing to participate in the research

exclusion criteria: Not willing to participate in the research, Having communication problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reiki Group
Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
Patients were informed about the application, and a Reiki application video prepared/selected by the researchers was shared with the patients. Patients were asked to perform Reiki every day for a week following each chemotherapy session for 4 cycles. A reminder message was sent to the patients the day before each cycle for the Reiki application. The level of hopelessness was reassessed at the end of each week.
No Intervention: control group
Only data collection forms were filled in the control group. No intervention was made.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The research data will be collected using the "Individual Information Form" and the "Beck Hopelessness Scale" prepared by the researchers in line with the literature.
Time Frame: The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.

Individual Information Form: The form prepared by the researchers consists of 14 questions.

Beck Hopelessness Scale: The Beck Hopelessness Scale was developed by Beck and colleagues in 1974 to determine the degree of pessimism an individual has about the future. The scale consists of 20 items in a five-point Likert format. The questions are answered as true or false and reflect negative expectations. Each answer that matches the given key scores 1 point, while answers that do not match score 0 points. The total score obtained is considered the "hopelessness" score, with higher scores indicating higher levels of hopelessness. The scale's score range is 0-20. The questions on the scale cover emotional, motivational, and cognitive dimensions. The scale consists of three factors: "Feelings about the Future," "Loss of Motivation," and "Future Expectations" (Durak & Palabıyıkoğlu, 1994). In this study, the Cronbach's Alpha value for hopelessness was calculated as 0.952.

The research data were collected through face-to-face and telephone interviews after obtaining ethical committee approval. The time required for individuals to complete the forms is approximately 10 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gamze TEMİZ, Dr, Saglik Bilimleri Universitesi

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Actual)

March 31, 2025

Study Completion (Actual)

March 31, 2025

Study Registration Dates

First Submitted

April 7, 2025

First Submitted That Met QC Criteria

April 24, 2025

First Posted (Actual)

May 1, 2025

Study Record Updates

Last Update Posted (Actual)

May 1, 2025

Last Update Submitted That Met QC Criteria

April 24, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Reiki and Oncology Patients (Registry Identifier: Reiki and Oncology Patients)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Oncology Patients

Clinical Trials on Reiki Group

Subscribe